BioStem Technologies to acquire wound care products and technologies from ProgenaCare Global
BioStem Technologies to acquire wound care products and technologies from ProgenaCare Global
200.38MUSD
Type
Common Stock
Exchange
OTCQB
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US0906842002
CUSIP
090684200
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
8.33
PEG Ratio
-
Book Value
2.85
Dividend Share
-
Dividend Yield
-
Earnings Share
1.47
Wall Street Target Price
35.50
EPS Estimate Current Year
1.17
EPS Estimate Next Year
2.72
EPS Estimate Current Quarter
0.47
EPS Estimate Next Quarter
0.65
Most Recent Quarter
-
Revenue TTM
332,451,200
Gross Profit TTM
320,076,640
EBITDA
32,055,466
Profit Margin
9.96%
Return On Assets TTM
20.41%
Return On Equity TTM
122.26%
Revenue Per Share TTM
20.2
Qtly Revenue Growth YOY
73.10%
Diluted Eps TTM
1.47
Qtly Earnings Growth YOY
0.00%
Trailing PE
8.33
Forward PE
10
Price Sales TTM
0.6151
Price Book MRQ
5.0027
Enterprise Value Revenue
0
Enterprise Value EBITDA
5
158.80
4.35%568.00
1.50%547.60
0.00%203.85
0.00%313.00
-2.97%468.00
-2.44%79.11
-2.01%250.30
-1.29%556.69
-1.26%100.26
-0.67%